223 related articles for article (PubMed ID: 26967517)
1. Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
O'Connell S; Lillis D; Cotter A; O'Dea S; Tuite H; Fleming C; Crowley B; Fitzgerald I; Dalby L; Barry H; Shields D; Norris S; Plunkett PK; Bergin C
PLoS One; 2016; 11(3):e0150546. PubMed ID: 26967517
[TBL] [Abstract][Full Text] [Related]
2. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
[TBL] [Abstract][Full Text] [Related]
4. Opt-out bloodborne virus screening: a cross-sectional observational study in an acute medical unit.
Allen N; Faherty C; Davies A; Lyons A; Scarry M; Bohan Keane M; Boyle N; O'Connell S; McCarthy E; Keady D; Bergin C; Lee J; Fleming C; Gallagher D; Tuite H
BMJ Open; 2019 Jul; 9(7):e022777. PubMed ID: 31315851
[TBL] [Abstract][Full Text] [Related]
5. Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study.
O'Kelly M; Byrne D; Naughten E; Bergin C; Williams C
Br J Gen Pract; 2016 Jun; 66(647):e392-6. PubMed ID: 27114211
[TBL] [Abstract][Full Text] [Related]
6. HIV/HCV/HBV testing in the emergency department: a feasibility and seroprevalence study.
Bradshaw D; Rae C; Rayment M; Turner N; Turner R; Pickard G; Pillay K; Roberts P; Foxton M; Sullivan AK
HIV Med; 2018 Feb; 19 Suppl 1():52-57. PubMed ID: 29488696
[TBL] [Abstract][Full Text] [Related]
7. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
Evans H; Balasegaram S; Douthwaite S; Hunter L; Kulasegaram R; Wong T; Querol-Rubiera A; Nebbia G
PLoS One; 2018; 13(7):e0198520. PubMed ID: 30044779
[TBL] [Abstract][Full Text] [Related]
8. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
9. Opt-out screening for HIV, hepatitis B and hepatitis C: observational study of screening acceptance, yield and treatment outcomes.
Grant C; O'Connell S; Lillis D; Moriarty A; Fitzgerald I; Dalby L; Bannan C; Tuite H; Crowley B; Plunkett P; Kennedy U; McMahon G; McKiernan S; Norris S; Hughes G; Shields D; Bergin C
Emerg Med J; 2020 Feb; 37(2):102-105. PubMed ID: 31806726
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
Bundle N; Balasegaram S; Parry S; Ullah S; Harris RJ; Ahmad K; Foster GR; Tong CY; Orkin C
Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290390
[TBL] [Abstract][Full Text] [Related]
11. An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses.
Thai KTD; Götz H; Slingerland BCGC; Klaasse J; Schutten M; GeurtsvanKessel CH
J Clin Virol; 2018 May; 102():95-100. PubMed ID: 29547874
[TBL] [Abstract][Full Text] [Related]
12. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.
Bil JP; Schrooders PA; Prins M; Kouw PM; Klomp JH; Scholing M; Huijbregts LP; Sonder GJ; Waegemaekers TC; de Vries HJ; Meijer W; Zuure FR; Tostmann A
Euro Surveill; 2018 Mar; 23(11):. PubMed ID: 29560855
[TBL] [Abstract][Full Text] [Related]
13. Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department - uncovering the iceberg?
Parry S; Bundle N; Ullah S; Foster GR; Ahmad K; Tong CYW; Balasegaram S; Orkin C
Epidemiol Infect; 2018 Jun; 146(8):1026-1035. PubMed ID: 29661260
[TBL] [Abstract][Full Text] [Related]
14. Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital.
Zeng J; Macdonald D; Durkin R; Irish D; Hart J; Haque T
J Clin Virol; 2023 Dec; 169():105615. PubMed ID: 37948983
[TBL] [Abstract][Full Text] [Related]
15. VirA+EmiC project: Evaluating real-world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department.
Nebbia G; Ruf M; Hunter L; Balasegaram S; Wong T; Kulasegaram R; Surey J; Khan Z; Williams J; Karo B; Snell L; Flower B; Evans H; Douthwaite S
J Viral Hepat; 2022 Jul; 29(7):559-568. PubMed ID: 35357750
[TBL] [Abstract][Full Text] [Related]
16. Real-world clinical effectiveness and sustainability of universal bloodborne virus testing in an urban emergency department in the UK.
Smout E; Phyu K; Hughes GJ; Parker L; Rezai R; Evans A; McLaren J; Bush S; Davey S; Aldersley MA; Ruf M; Page EE
Sci Rep; 2022 Nov; 12(1):19257. PubMed ID: 36357472
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
19. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
[TBL] [Abstract][Full Text] [Related]
20. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
Edeh J; Spalding P
J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
